[1
]Institute of Experimental Cancer Research, Department of Internal Medicine III, University
Hospital Ulm
[2
]Department of Medicine III at LMU Hospital, Munich, Germany
[3
]Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain
[4
]MBChB, MD, FRCP, FRCPath, FMedSci, Professor of Haemato-oncology, Centre for Haematology,
Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0HS, United
Kingdom
[5
]Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department
of Molecular Medicine, University of Pavia, Pavia, Italy
[6
]Service d’Hématologie Oncologie, Centre Hospitalier de Versailles, Le Chesnay, 78150,
France ; UVSQ, Inserm, CESP, 94805, Villejuif, France
[7
]Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum,
Berlin, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität
Berlin and Humboldt-Universität zu Berlin, 13353 Berlin, Germany
[8
]University of Milan & Hematology Division, Fondazione IRCCS Istituto Nazionale dei
Tumori di Milano
[9
]Cancer Center, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milan,
Italy; Humanitas University, Department of Biomedical Sciences, Via Rita Levi Montalcini
4, 20090 Pieve Emanuele – Milan, Italy
[10
]Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian
University of Athens, Athens, Greece
[11
]Consultant Haematologist & Hon Associate Professor, UCLH Centre for Waldenström and
Neurohaematology, University College London Hospitals NHS Foundation Trust, London,
United Kingdom
[12
]Department of Radiation Oncology, University of Muenster, Germany
[13
]Hematology, Department of Translational and Precision Medicine, Sapienza University,
Rome, Italy
[14
]Strategic Research Program on Chronic Lymphocytic Leukemia and Laboratory of B Cell
Neoplasia, Division of Molecular Oncology, Università Vita-Salute San Raffaele, and
IRCCS Ospedale San Raffaele, Milano, Italy
[15
]Department Of Hematology, Portuguese Institute of Oncology, Lisbon, Portugal
[16
]Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
[17
]Department of Hematooncology University Hospital Ostrava, Department of Hematooncology,
Faculty of Medicine, University of Ostrava
[18
]Clinical Director - Haematology, Haemostasis, Palliative Care, Cellular Pathology
Guy's and St Thomas' NHS Foundation Trust , London, United Kingdom
[19
]Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover
Medical School, Hannover, Germany
[20
]Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna,
Austria
[21
]Université de Paris, APHP, Hôpital Saint-Louis, Centre d’Investigations Cliniques,
INSERM CIC 1427, Paris, France
[22
]MD, Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf,
Martinistrasse 52, D-20246 Hamburg, Germany
[23
]Hematology department, University hospital hotel-dieu, place ricordeau, 44093 Nantes,
France
[24
]Hematology Division, Basel University Hospital, Basel Switzerland
[25
]Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia
and Thrombosis Center, Milan, Italy; Department of Pathophysiology and Transplantation,
University of Milan, Milan, Italy
[26
]Département médico universitaire d'hématologie et immunologie, France Intergroupe
des Leucémies Myéloïdes Chroniques (Fi-LMC), Hôpital Saint-Louis, Paris, France
[27
]MD, PhD, Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol, Josep
Carreras Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain
[28
]Department of Hematology, Medical University of Lodz, Lodz, Poland
[29
]Clínica Universidad de Navarra (CUN), Centro de Investigación Aplicada (CIMA), Instituto
de Investigación Sanitaria de Navarra (IDISNA), CIBERONC, 31008 Pamplona, Spain
[30
]MDS Unit, Hematology, DMSC, AOUC, University Of Florence, Firenze, Italy
[31
]Hematology Department, Hospital Univesitario y Politecnico La Fe, Valencia, Spain;
CIBERONC, IS Carlos III, Madrid, Spain
[32
]Erasmus MC Cancer Institute, Dept. of Hematolog, Rotterdam, the Netherlands
[33
]Department of Hematology and Medical Oncology, University Hospital Jena, Jena, Germany;
Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute,
Jena, Germany
[34
]Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilian University,
Munich, Germany
[35
]Scientific and Medical Division, ESMO European Society for Medical Oncology, Lugano,
Switzerland
[36
]Department of Medicine and Surgery, University of Insubria, Varese, Italy
License:
Since January 2020 Elsevier has created a COVID-19 resource centre with free information
in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre
is hosted on Elsevier Connect, the company's public news and information website.
Elsevier hereby grants permission to make all its COVID-19-related research that is
available on the COVID-19 resource centre - including this research content - immediately
available in PubMed Central and other publicly funded repositories, such as the WHO
COVID database with rights for unrestricted research re-use and analyses in any form
or by any means with acknowledgement of the original source. These permissions are
granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
